Publications by authors named "Sakra Balhareth"

Claim this Profile
C
Challenges in evaluation and reimbursement of drugs for rare diseases in Saudi Arabia: a Delphi expert consensus.
Laila Carolina Abu Esba, Consuela Cheriece Yousef, Mansoor Ahmed Khan, Sakra Balhareth, Hussain A Al-Omar

J Pharm Policy Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a specialty pharmacy in an ambulatory care setting in Saudi Arabia: Patient experience and operational outcomes.
Abdulrazaq S Al-Jazairi, Roa'a Al-Gain, Nasser I Alrubayan, Alhanouf F Almousa, Lina M Aldawood, Sakra S Balhareth

J Am Pharm Assoc (2003)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Life Evaluation in Saudi Arabian Pediatric Patients with Primary Immunodeficiency Diseases Receiving 20% Subcutaneous IgG Infusions at Home.
Bandar Al-Saud, Nora AlRumayyan, Areej Alfattani, Sawsan Abu Awwad, Dema Al Saud, Sakra S Balhareth

J Clin Immunol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacy service accreditation: Raising the bar of practice standards.
Abdulrazaq Al-Jazairi, Sakra Balhareth, Delal Alkortas, Hanadi Muawad, Roa'a Al-Gain

J Am Pharm Assoc (2003)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization and cost of electronic resources in adult cancer center.
Fatma Maraiki, Siobhan Kelly, Mohamed Ahmed, Sakra Balhareth, Tusneem Elhasan

BMC Res Notes· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A three-year study of a first-generation chemotherapy-compounding robot.
Zubeir Nurgat, Dima Faris, Maher Mominah, Arris Vibar, Abdulrazaq Al-Jazairi, Sakra Balhareth

Am J Health Syst Pharm· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of foetal risk associated with 93 non-US-FDA approved medications during pregnancy.
Ahmed H Al-Jedai, Sakra S Balhareth, Roaa A Algain

Saudi Pharm J· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis